JoinClinicalTrials.com

• Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis

  NCT03520439

  Condition:   Adenomyosis
  Interventions:   Drug: Mifepristone;   Drug: Placebo
  Sponsors:   xinmei zhang;   Anhui Province Cancer Hospital;   Huzhou Maternity and Child Care Hospital;   Jiaxing Maternity and Child Health Care Hospital;   Jinhua Municipal Central Hospital;   The Central Hospital of Lishui City;   The Affiliated Hospital of Medical School of Ningbo University;   Ningbo Maternity and Child Care Hospital;   The People's Hospital of Quzhou;   Shaoxing Women and Children's Hospital;   First Affiliated Hospital of Wenzhou Medical University;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Sir Run Run Shaw Hospital;   Taizhou First People's Hospital;   Zhoushan Maternity and Infant Hospital;   Shaoxing People's Hospital
  Recruiting
• Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.

  NCT03946722

  Condition:   Adenomyosis
  Interventions:   Drug: GnRH analogue downregulation;   Procedure: Uterine flushing;   Other: Patient questionnaire
  Sponsor:   University College, London
  Not yet recruiting
• Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

  NCT03654144

  Condition:   Adenomyosis
  Interventions:   Drug: Dienogest;   Drug: Combined Oral Contraceptive
  Sponsor:   Assiut University
  Not yet recruiting
• Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis

  NCT03940807

  Condition:   Adenomyosis
  Interventions:   Drug: 11.25mg GnRH agonist;   Drug: 0.1 mg GnRH agonist;   Drug: 25 µg transdermal oestradiol
  Sponsor:   University Hospital, Toulouse
  Not yet recruiting
• Adenomyosis: Genomic Mechanisms and Biological Response

  NCT03428854

  Conditions:   Adenomyosis;   Abnormal Uterine Bleeding
  Intervention:   Drug: LNG-IUS
  Sponsor:   University of Texas Southwestern Medical Center
  Not yet recruiting
• Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis

  NCT03302468

  Conditions:   Endometriosis;   Adenomyosis
  Intervention:  
  Sponsor:   Chinese University of Hong Kong
  Recruiting
• The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms

  NCT02495311

  Conditions:   Adenomyosis;   Uterine Leiomyoma
  Intervention:   Procedure: myomectomy or adenomyomectomy
  Sponsor:   Far Eastern Memorial Hospital
  Recruiting
• Dienogest for Treatment of Adenomyotic Uteri

  NCT03890042

  Condition:   Adenomyosis
  Interventions:   Drug: Dienogest group;   Drug: Gestodene-Ethinyl Estradiol;   Radiation: Ultrasound;   Other: visual analogue scale
  Sponsor:   Assiut University
  Recruiting
• Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis

  NCT04010487

  Conditions:   Adenomyosis;   Endometrial Cancer;   Ectopic Endometrial Tissue;   Eutopic Endometrium;   Genomics;   Transcriptomics
  Intervention:   Genetic: whole exome sequencing and RNA-sequencing
  Sponsor:   Lei Li
  Recruiting
• A Multi-omics Study of Adenomyosis

  NCT03742843

  Conditions:   Adenomyosis;   Endometriosis;   Ectopic Endometrium;   Eutopic Endometrium;   Genomics;   Transcriptomics;   Metabolomics
  Intervention:   Combination Product: A multi-omics analysis
  Sponsor:   Lei Li
  Recruiting
• Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis

  NCT03749109

  Condition:   Endometriosis
  Interventions:   Drug: Quinagolide 1080 µg;   Drug: Placebo
  Sponsor:   Ferring Pharmaceuticals
  Recruiting
• Cooperative Adenomyosis Network

  NCT03230994

  Conditions:   Dysmenorrhea;   Metrorrhagia;   Infertility, Female;   Pathology;   Ultrasonography;   Radiography
  Intervention:  
  Sponsor:   Peking Union Medical College Hospital
  Recruiting
• Paracervical Block in Laparoscopic Hysterectomy

  NCT03792009

  Conditions:   Uterine Fibroid;   Adenomyosis
  Interventions:   Device: Paracervical block;   Drug: 5% bupivacaine;   Drug: Normal saline
  Sponsor:   Kangbuk Samsung Hospital
  Recruiting
• Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)

  NCT02914704

  Conditions:   Uterine Fibroids;   Adenomyosis
  Intervention:   Device: MRI-HIFU
  Sponsor:   Turku University Hospital
  Recruiting
• Drainage or Not for Laparoscopic Cholecystetomy

  NCT03909360

  Conditions:   Cholecystitis;   Cholecystolithiasis;   Polyps Gallbladder;   Adenomyosis of Gallbladder
  Intervention:   Procedure: drainage tube
  Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
  Recruiting
• ICG to Assess Ovarian Perfusion

  NCT03927651

  Conditions:   Fibroid Uterus;   Endometriosis;   Uterus Myoma;   Uterine Fibroid;   Uterine Adenomyosis;   Endometrial Cyst;   Uterine Cyst
  Intervention:   Drug: ICG
  Sponsor:   Northwestern University
  Recruiting